
Newsletter
Promoter: | ShiznitStocks | Paying Party: | UNKNOWN |
Stocks covered: | Compensation: | Avg $ Volume for Period: |
RXSF | $2000 | UNKNOWN |
Max Profit: 10.00 % | Gain at close: 0.00 % | |
*We think that this promoter is a part of a group of promoters. |

![]() Hello fellow investors / traders, My trade ideas today were mixed. One gained around 7% and held its gains most of the day, the other gained almost 20% at the open and then sold off.
But as I alluded to earlier in the morning, I've been working on some bigger picks and waiting for the perfect setup. And that time has come. Enter RX Safes Inc (RXSF). RXSF is a new "IPO style" play with a clean chart that has pulled back massively from where it started trading. Just check out the chart below and you'll see what I mean.
RXSF is making a concerted effort to get its name out in front of the investing community - just like our pick AAWC last week that gave us 33% gains in one day. Put simply, we are expecting big things from RXSF tomorrow and next week. This is your official "early bird" alert so you can get in before the crowd. With the beaten down chart and tiny float, we could easily see RXSF get back to $0.10+ tomorrow and into next week. Rx Safes (RXSF) is an emerging leader in the personal and professional healthcare drug security market. Since drug abuse and drug diversion starts with unauthorized access, their products incorporate proprietary patented fingerprint technology to provide drug security solutions for use in homes and healthcare facilities. Prescription drug misuse, skyrocketing insurance and pharmaceutical treatment costs and increased regulatory pressures create an unfortunate, yet necessary opportunity for Rx Safes to expand their reach and offerings in this growing market, valued at over $50 billion annually. Annual spending on healthcare technology products exceeds $34.5 billion. In addition, the market is being driven by ongoing Government support for successful drug abuse prevention initiatives, with a financial commitment of $25.4 billion in 2015 alone. The team at RXSF has over 20 years of experience in designing and manufacturing fingerprint security products for some of the biggest companies including Master Lock Corporation, Overhead Door Company, Hewlett-Packard, Kodak and SentrySafe. Their products have been tested by such organizations as The Good Housekeeping Research Institute, Underwriters Laboratories and the Pratt Institute for Technology. RXSF's current corporate partners include the biggest and most trusted names in the medical device and supply markets such as McKesson and Cardinal Health. The Company also holds several patents and licenses to exclusively develop and offer this product for sale in North America. Just a few weeks ago, RXSF secured a massive $10m credit line that will help them grow their business. For more information, please visit www.rxdrugsafe.com. I promise you one thing. RXSF has all the potential to be our biggest winner yet for 2015. Make sure you are ready to trade tomorrow at the opening bell. Disclaimer Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. For full disclaimer click here. ShiznitStocks.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. The disclaimer is to be read and fully understood before using our site, or joining our email list. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead ShiznitStocks.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. ShiznitStocks.com does not offer such advice or analysis, and ShiznitStocks.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, ShiznitStocks.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, ShiznitStocks.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents have not completed any due diligence or research on the companies advertised herein and disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. ShiznitStocks.com is not responsible for any claims made by the companies advertised herein. ShiznitStocks.com may receive compensation and its employees and affiliates may own stock that they have purchased in the open market either prior, during, or after the release of the companies profile which is an inherent conflict of interest in ShiznitStocks.com statements and opinions and such statements and opinions cannot be considered independent. ShiznitStocks.com reserves the right to buy and sell shares of the profiled company on the open market before, during or after the release of the company profile. In such an event, ShiznitStocks.com will not update its disclaimer to reflect any shares bought or sold on the open market during the profile coverage. ShiznitStocks.com and its management may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the companies profile. ShiznitStocks.com has been compensated two thousand dollars via electronic transfer from a non-affiliated third party for the profile of RXSF. ShiznitStocks.com may on occasion accept compensation in restricted or free-trading shares for it's marketing services of the company being profiled, and the third party that might have compensated ShiznitStocks.com may hold free-trading shares of the company being profiled and could very well be selling shares of the companies stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration. If ShiznitStocks.com ever accepts compensation in the form of restricted or free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the companies profile our disclaimer will be updated accordingly reflecting the current position of those free trading shares received as compensation for our services. |
21 Ocean Ave, Marina Del Ray, Los Angeles, CA 90292